Výsledky vyhledávání - Guilhot, Francois
- Zobrazuji výsledky 1 - 20 z 33
- Přejít na další stránku
-
1
-
2
-
3
Early onset hypercholesterolemia induced by the 2(nd)-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia Autor Rea, Delphine, Mirault, Tristan, Cluzeau, Thomas, Gautier, Jean-François, Guilhot, François, Dombret, Hervé, Messas, Emmanuel
Vydáno 2014Text -
4
Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients Autor Breccia, Massimo, Baccarani, Michele, Rosti, Gianantonio, Cottone, Francesco, Cannella, Laura, Guilhot, François, Vignetti, Marco, Efficace, Fabio
Vydáno 2017Text -
5
High rates of durable response are achieved with imatinib after treatment with interferon α plus cytarabine: results from the International Randomized Study of Interferon and STI57... Autor Guilhot, François, Druker, Brian, Larson, Richard A., Gathmann, Insa, So, Charlene, Waltzman, Roger, O’Brien, Stephen G.
Vydáno 2009Text -
6
Comprehensive Characterization of a Novel Intronic Pseudo-Exon Inserted within an e14/a2 BCR-ABL Rearrangement in a Patient with Chronic Myeloid Leukemia Autor Sorel, Nathalie, Mayeur-Rousse, Caroline, Deverrière, Séverine, Roy, Lydia, Brottier-Mancini, Elisabeth, Guilhot, François, Turhan, Ali G., Chomel, Jean Claude
Vydáno 2010Text -
7
Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial Autor Guilhot, François, Hughes, Timothy P., Cortes, Jorge, Druker, Brian J., Baccarani, Michele, Gathmann, Insa, Hayes, Michael, Granvil, Camille, Wang, Yanfeng
Vydáno 2012Text -
8
Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia Autor Flamant, Stéphane, Ritchie, William, Guilhot, Joëlle, Holst, Jeff, Bonnet, Marie-Laure, Chomel, Jean-Claude, Guilhot, François, Turhan, Ali G., Rasko, John E.J.
Vydáno 2010Text -
9
Efficacy of Imatinib Dose Escalation in Patients With Chronic Myeloid Leukemia in Chronic Phase Autor Kantarjian, Hagop M., Larson, Richard A., Guilhot, Francois, O’Brien, Stephen G., Mone, Manisha, Rudoltz, Marc, Krahnke, Tillmann, Cortes, Jorge, Druker, Brian J.
Vydáno 2009Text -
10
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial Autor Brümmendorf, Tim H, Cortes, Jorge E, de Souza, Cármino Antonio, Guilhot, Francois, Duvillié, Ladan, Pavlov, Dmitri, Gogat, Karïn, Countouriotis, Athena M, Gambacorti-Passerini, Carlo
Vydáno 2015Text -
11
Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease Autor Chomel, Jean-Claude, Bonnet, Marie-Laure, Sorel, Nathalie, Bertrand, Angelina, Meunier, Marie-Claude, Fichelson, Serge, Melkus, Michael, Bennaceur-Griscelli, Annelise, Guilhot, François, Turhan, Ali G.
Vydáno 2011Text -
12
High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients Autor Delord, Marc, Rousselot, Philippe, Cayuela, Jean Michel, Sigaux, François, Guilhot, Joëlle, Preudhomme, Claude, Guilhot, François, Loiseau, Pascale, Raffoux, Emmanuel, Geromin, Daniela, Génin, Emmanuelle, Calvo, Fabien, Bruzzoni-Giovanelli, Heriberto
Vydáno 2013Text -
13
The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia Autor Jacomet, Florence, Cayssials, Emilie, Barbarin, Alice, Desmier, Deborah, Basbous, Sara, Lefèvre, Lucie, Levescot, Anaïs, Robin, Aurélie, Piccirilli, Nathalie, Giraud, Christine, Guilhot, François, Roy, Lydia, Herbelin, André, Gombert, Jean-Marc
Vydáno 2017Text -
14
Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study Autor Shah, Neil P., Guilhot, François, Cortes, Jorge E., Schiffer, Charles A., le Coutre, Philipp, Brümmendorf, Tim H., Kantarjian, Hagop M., Hochhaus, Andreas, Rousselot, Philippe, Mohamed, Hesham, Healey, Diane, Cunningham, Michael, Saglio, Giuseppe
Vydáno 2014Text -
15
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imati... Autor Hughes, Timothy P., Hochhaus, Andreas, Kantarjian, Hagop M., Cervantes, Francisco, Guilhot, François, Niederwieser, Dietger, le Coutre, Philipp D., Rosti, Gianantonio, Ossenkoppele, Gert, Lobo, Clarisse, Shibayama, Hirohiko, Fan, Xiaolin, Menssen, Hans D., Kemp, Charisse, Larson, Richard A., Saglio, Giuseppe
Vydáno 2014Text -
16
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia Autor Hochhaus, Andreas, Larson, Richard A., Guilhot, François, Radich, Jerald P., Branford, Susan, Hughes, Timothy P., Baccarani, Michele, Deininger, Michael W., Cervantes, Francisco, Fujihara, Satoko, Ortmann, Christine-Elke, Menssen, Hans D., Kantarjian, Hagop, O’Brien, Stephen G., Druker, Brian J.
Vydáno 2017Text -
17
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interf... Autor Hughes, Timothy P., Hochhaus, Andreas, Branford, Susan, Müller, Martin C., Kaeda, Jaspal S., Foroni, Letizia, Druker, Brian J., Guilhot, François, Larson, Richard A., O'Brien, Stephen G., Rudoltz, Marc S., Mone, Manisha, Wehrle, Elisabeth, Modur, Vijay, Goldman, John M., Radich, Jerald P.
Vydáno 2010Text -
18
Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet Autor Baccarani, Michele, Cortes, Jorge, Pane, Fabrizio, Niederwieser, Dietger, Saglio, Giuseppe, Apperley, Jane, Cervantes, Francisco, Deininger, Michael, Gratwohl, Alois, Guilhot, François, Hochhaus, Andreas, Horowitz, Mary, Hughes, Timothy, Kantarjian, Hagop, Larson, Richard, Radich, Jerald, Simonsson, Bengt, Silver, Richard T., Goldman, John, Hehlmann, Rudiger
Vydáno 2009Text -
19
Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma Autor Lodé, Laurence, Eveillard, Marion, Trichet, Valérie, Soussi, Thierry, Wuillème, Soraya, Richebourg, Steven, Magrangeas, Florence, Ifrah, Norbert, Campion, Loïc, Traullé, Catherine, Guilhot, François, Caillot, Denis, Marit, Gérald, Mathiot, Claire, Facon, Thierry, Attal, Michel, Harousseau, Jean-Luc, Moreau, Philippe, Minvielle, Stéphane, Avet-Loiseau, Hervé
Vydáno 2010Text -
20
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study Autor Rousselot, Philippe, Prost, Stéphane, Guilhot, Joelle, Roy, Lydia, Etienne, Gabriel, Legros, Laurence, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Huguet, Francoise, Cayssials, Emilie, Cayuela, Jean‐Michel, Relouzat, Francis, Delord, Marc, Bruzzoni‐Giovanelli, Heriberto, Morisset, Laure, Mahon, François‐Xavier, Guilhot, François, Leboulch, Philippe
Vydáno 2016Text